Compare Novartis AG (NVS) vs Vanguard Real Estate Index Fund ETF (VNQ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novartis AG vs Vanguard Real Estate Index Fund ETF — how do they compare? Novartis AG trades at $152.79 (market cap $295.37B), while Vanguard Real Estate Index Fund ETF trades at $97.3. The key difference: Novartis AG pays a 3.07% dividend while Vanguard Real Estate Index Fund ETF pays none. Which is the better fit depends on your goals.
| NVS | VNQ | |
|---|---|---|
Market Cap | $295.37B | — |
Sector | Health | — |
52-Week High | $168.62 | $100.95 |
52-Week Low | $119.31 | $87.00 |
Enterprise Value | $336.69B | — |
Dividend Yield | 3.07% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Novartis AG (NVS) trades at $156.79, up 0.29% today, with a bullish technical signal from moving averages and recent Q2 2026 earnings beating estimates. Strong profitability is evident with a 74.74% gross margin and 22.5% net margin, while revenue grew to $56.67B in 2025. The stock faces resistance near $157, with support at $156.
The outlook is positive due to robust drug pipeline progress and reaffirmed 2026 guidance, though risks include generic competition for Entresto and pricing pressures. Analyst sentiment is mixed with 24% buy ratings, but institutional buying activity supports confidence in long-term growth.
VNQ (Vanguard Real Estate ETF) trades at $96.745, down 0.38% on the day amid a bearish technical signal. The ETF shows mixed momentum with oversold short-term RSI readings but bearish moving averages. Recent institutional selling activity from firms like Bank of America and City Holding Co. indicates cautious positioning in the real estate sector. The fund's dividend yield remains a key attraction for income-focused investors.
The outlook for VNQ is challenged by rising interest rate sensitivity and institutional outflows, though the oversold RSI suggests potential for near-term stabilization. Investors should weigh the ETF's low expense ratio and U.S. REIT diversification against sector-specific headwinds including commercial real estate pressures and economic uncertainty.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →About Vanguard Real Estate Index Fund ETF
The fund employs an indexing investment approach designed to track the performance of the MSCI US Investable Market Real Estate 25/50 Index, an index made up of stocks of large, mid-size, and small US companies within the real estate sector. The Advisor attempts to replicate the target index by seeking to invest all of its assets in the stocks that make up the index, in order to hold each stock in approximately the same proportion as its weighting in the index. It is non-diversified.
Read more on VNQ →
